Omnicell (OMCL) Acquisitions (2012 - 2022)

Omnicell (OMCL) posted quarterly Acquisitions of $3.4 million for Q1 2022, down 98.07% quarter-over-quarter from $176.1 million in Q4 2021.

Omnicell (OMCL) Acquisitions (2012 - 2022) Analysis & Trends

Omnicell (OMCL) has reported Acquisitions for 8 consecutive years, with $3.4 million the latest figure, recorded in Q1 2022.

In Q1 2022, Acquisitions changed N/A year-over-year to $3.4 million; the TTM figure through Dec 2022 stood at $3.4 million (down 99.04% YoY), while the FY2022 annual figure was $3.4 million, down 99.04% from the prior year.
Acquisitions eased to $3.4 million in Q1 2022 per OMCL's latest filing, from $176.1 million in the prior quarter.
Across five years, Acquisitions topped out at $225.0 million in Q4 2020 and bottomed at $3.4 million in Q1 2022.
Historically, Acquisitions has averaged $145.6 million across 3 years, with a median of $177.1 million in 2021.
On a YoY basis, Acquisitions climbed as much as 21.74% in 2021 and fell as far as 21.74% in 2021.
Omnicell's Acquisitions stood at $225.0 million in 2020, then dropped by 21.74% to $176.1 million in 2021, then sank by 98.07% to $3.4 million in 2022.
Business Quant data shows OMCL's Acquisitions at $3.4 million in Q1 2022, $176.1 million in Q4 2021, and $178.1 million in Q3 2021.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Acquisitions (Qtr)
1	Veeva Systems	39.72 Bn	32.40 Bn	662.02 Mn	75.48 Mn
2	BrightSpring Health Services	12.19 Bn	11.64 Bn	492.75 Mn	-
3	Healthequity	8.79 Bn	8.52 Bn	256.31 Mn	-
4	10x Genomics	7.31 Bn	6.76 Bn	112.50 Mn	-
5	Hinge Health	7.10 Bn	6.71 Bn	183.95 Mn	-
6	MiniMed	5.66 Bn	5.36 Bn	480.00 Mn	-
7	Waystar Holding	4.76 Bn	4.56 Bn	221.99 Mn	-
8	Doximity	4.46 Bn	3.77 Bn	132.93 Mn	-
9	Heartflow	3.66 Bn	3.28 Bn	53.19 Mn	-
10	Omnicell	1.70 Bn	1.41 Bn	152.94 Mn	-

Download Data